Estudo comparativo do possível efeito protetor da vitamina e na injúria pulmonar obtida por administração de doxorrubicina em ratos

Estudo comparativo do possível efeito protetor da vitamina e na injúria pulmonar obtida por administração de doxorrubicina em ratos

OBJETIVO: A doxorrubicina, um dos fármacos mais utilizados no tratamento do câncer, apresenta toxicidade cardiopulmonar acentuada, muitas vezes impedindo o tratamento completo. O tocoferol (vitamina E), por sua vez, demonstrou atenuar os efeitos cardiotóxicos provocados pela doxorrubicina, permitind...

Full description

Bibliographic Details
Main Authors:	Luiz Augusto Lopes da Costa, Vanessa Niemiec Teixeira, Airton Schneider
Format:	Article
Language:	English
Published:	Colégio Brasileiro de Cirurgiões
Series:	Revista do Colégio Brasileiro de Cirurgiões
Subjects:	Tocopherol Vitamin E Doxorubicin Adriamycin Lung Lung Injury
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912004000400008&lng=en&tlng=en

Similar Items

Doxorubicin-induced cardiotoxicity is suppressed by estrous-staged treatment and exogenous 17β-estradiol in female tumor-bearing spontaneously hypertensive rats
by: Kaytee L. Pokrzywinski, et al.
Published: (2018-06-01)

Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
by: Barrett D. Allen, et al.
Published: (2019-11-01)

Two-Mechanism Peak Concentration Model for Cellular Pharmacodynamics of Doxorubicin
by: Ardith W. El-Kareh, et al.
Published: (2005-07-01)

Chondroitin sulfate modified and adriamycin preloaded hybrid nanoparticles for tumor‐targeted chemotherapy of lung cancer
by: Xiang Liang, et al.
Published: (2021-05-01)

Vitamin E Isoforms as Modulators of Lung Inflammation
by: Hiam Abdala-Valencia, et al.
Published: (2013-10-01)

Dataset on chemotherapy-induced nausea and vomiting (CINV) and quality of life (QOL) during multiple chemotherapy cycles among a Chinese breast cancer patient population who were randomized to antiemetic regimens with or without olanzapine
by: Winnie Yeo, et al.
Published: (2020-06-01)

Perfil tóxico-farmacológico da administração da doxorrubicina em cães com tumor venéreo transmissível /
by: Assumpção, Juliana Uruguay Corrêa Vidigal.
Published: (2015)

Perfil tóxico-farmacológico da administração da doxorrubicina em cães com tumor venéreo transmissível
by: Assumpção, Juliana Uruguay Corrêa Vidigal [UNESP]
Published: (2016)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
by: Yingying Wang, et al.
Published: (2020-02-01)

Evaluation of Flavonoid Derivative and Doxorubicin Effects in Lung Cancer Cells (A549) Using Differential Pulse Voltammetry Method
by: Mohammad Amjadi, et al.
Published: (2018-11-01)

Influência do extrato de chá verde na remodelação cardíaca induzida por administração de doxorrubicina /
by: Modesto, Pamela Nayara.
Published: (2015)

Influência do extrato de chá verde na remodelação cardíaca induzida por administração de doxorrubicina
by: Modesto, Pamela Nayara [UNESP]
Published: (2015)

Mecanismos envolvidos na cardiotoxidade aguda induzida pela doxorrubicina em ratos
by: Polegato, Bertha Furlan [UNESP]
Published: (2014)

Assessment of the Nutraceutical Effects of Oleuropein and the Cytotoxic Effects of Adriamycin, When Administered Alone and in Combination, in MG-63 Human Osteosarcoma Cells
by: Katerina Gioti, et al.
Published: (2021-01-01)

Adriamycin - efficacy and possible adverse effects
by: Pedrycz Agnieszka, et al.
Published: (2016-03-01)

Farmacocinética pré-clínica e cardiotoxicidade da doxorrubicina veiculada por sistema microemulsionado /
by: Assumpção, Juliana Uruguay Corrêa Vidigal.
Published: (2011)

Prodigiosin-Emerged PI3K/Beclin-1-Independent Pathway Elicits Autophagic Cell Death in Doxorubicin-Sensitive and -Resistant Lung Cancer
by: Wei-Jun Chiu, et al.
Published: (2018-10-01)

Reversal of Doxorubicin-induced Cardiotoxicity by Using Phytotherapy: A Review
by: Azar Hosseini, et al.
Published: (2017-12-01)

Mucosal melanosis associated with chemoembolization
by: Ali Alkan, et al.
Published: (2015-06-01)

Farmacocinética pré-clínica e cardiotoxicidade da doxorrubicina veiculada por sistema microemulsionado
by: Assumpção, Juliana Uruguay Corrêa Vidigal [UNESP]
Published: (2014)

Preparation, Characterization and Evaluation of α-Tocopherol Succinate-Modified Dextran Micelles as Potential Drug Carriers
by: Jingmou Yu, et al.
Published: (2015-09-01)

Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy
by: Xinyi Zhang, et al.
Published: (2020-09-01)

Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCI-H82 variant small cell lung cancer
by: J.N. Moreira, et al.
Published: (2004-08-01)

Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles
by: Melguizo C, et al.
Published: (2015-12-01)

Doxyl Nitroxide Spin Probes Can Modify Toxicity of Doxorubicin towards Fibroblast Cells
by: Jan Czepas, et al.
Published: (2020-11-01)

Afatinib Sensibilizes Multidrug-resistant Human Ovarian Cancer Cells to Adriamycin and Related Mechanisms
by: ZHANG Yunqi, et al.
Published: (2018-10-01)

Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study
by: Jennifer Lindley Willcox, et al.
Published: (2020-07-01)

Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
by: Sami Al-Nadaf, et al.
Published: (2018-11-01)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
by: Le Van Manh Hung, et al.
Published: (2018-03-01)

Investigation of The Effects of Pleurotus Eryngii Extract on Adriamycin-İnduced Cardiotoxicity in Sprague-Dawley Rats
by: Elif Erdem Güzel
Published: (2021-06-01)

EFFECT OF SEVOFLURANE EXPOSURE ON ADRIAMYCIN-INDUCED INJURIES TO MYOCYTES
by: Li-hua Fan, et al.
Published: (2014-01-01)

Indução da cardiomiopatia dilatada com Doxorrubicina em modelo experimental com coelhos
by: Gava, Fábio Nelson [UNESP]
Published: (2014)

Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway
by: Cong Hou, et al.
Published: (2021-08-01)

Efeito antitumoral, citotoxicidade e farmacocinética da doxorrubicina incorporada em nanopartículas poliméricas e comparada a doxorrubicina comercializada na forma cloridrato e lipossomal. /
by: Candido, Caroline Damico.
Published: (2018)

Anatomopathological study of cardiomyopathy induced by doxorubicin in rats Estudo anatomopatológico da miocardiopatia induzida pela doxorrubicina em ratos
by: José Carlos Dorsa Vieira Pontes, et al.
Published: (2010-04-01)

Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy
by: Xia Y, et al.
Published: (2018-10-01)

Fibrosis pulmonar idiopática en un ecuatoriano adulto de la provincia de Riobamba
by: Leticia Remón Ramírez, et al.

Resecciones pulmonares: Morbilidad y mortalidad
by: Carlos Romero Díaz, et al.
Published: (2001-12-01)

Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition
by: Ryan N. Montalvo, et al.
Published: (2020-10-01)

Lisinopril Protects Against the Adriamycin Nephropathy and Reverses the Renalase Reduction: Potential Role of Renalase in Adriamycin Nephropathy
by: Pengxun Han, et al.
Published: (2013-09-01)